Nuclear deadenylation/polyadenylation factors regulate 3′ processing in response to DNA damage

EMBO Journal

Volumn 29, Issue 10, 2010, Pages 1674-1687

  Cevher, Murat A ^a   Zhang, Xiaokan ^a   Fernandez, Sully ^a   Kim, Sergey ^a   Baquero, Jorge ^a   Nilsson, Per ^b   Lee, Sean ^c   Virtanen, Anders ^b   Kleiman, Frida E ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

3 ; Deadenylation; DNA damage; Polyadenylation; RNA processing

Indexed keywords

BINDING PROTEIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CAP BINDING PROTEIN 80; MESSENGER RNA; NUCLEAR PROTEIN; POLY A SPECIFIC RIBONUCLEASE; PROTEIN CSTF 50; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DEADENYLATION; DNA DAMAGE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA CLEAVAGE; RNA PROCESSING; RNA TRANSCRIPTION; ULTRAVIOLET IRRADIATION;

CELL NUCLEUS; DNA DAMAGE; DNA REPAIR; EXORIBONUCLEASES; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; POLYADENYLATION; RECOMBINANT PROTEINS; RNA; RNA, MESSENGER; ULTRAVIOLET RAYS;

EID: 77952584028     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.59     Document Type: Article

References (62)

1. Akeo K, Funayama T, Hamada N, Akeo Y, Hiramitsu T, Kobayashi Y (2007) The effects of ultraviolet irradiation and hypoxia on expression of glutathione peroxidase and glyceraldehyde 3-phos-phate dehydrogenase in the cultured retinal pigment epithelium. Tissue Cult Res Commun 26: 149-157
2. Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E (2002) The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene 21: 4843-4848
3. Aström J, Aström A, Virtanen A (1991) In vitro deadenylation of mammalian mRNA by a HeLa cell 3 exonuclease. EMBO J 10: 3067-3071
4. Balatsos NA, Nilsson P, Mazza C, Cusack S, Virtanen A (2006) Inhibition of mRNA deadenylation by the nuclear cap binding complex (CBC). J Biol Chem 281: 4517-4522
5. Blattner C, Kannouche P, Litfin M, Bender K, Rahmsdorf HJ, Angulo JF, Herrlich P (2000) UV-induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol 20: 3616-3625
6. Bollig F, Winzen R, Kracht M, Ghebremedhin B, Ritter B, Wilhelm A, Resch K, Holtmann H (2002) Evidence for general stabilization of mRNAs in response to UV light. Eur J Biochem 26: 5830-5839
7. Chen CY, Shyu AB (2003) Rapid deadenylation triggered by a nonsense codon precedes decayof the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway. Mol Cell Biol 23: 4805-4813
8. Chuvpilo S, Zimmer M, Kerstan A, Glockner J, Avots A (1999) Alternative polyadenylation events contribute to the induction of NF-Atc in effector T cells. Immunity 10: 261-269
9. Colgan DF, Manley JL (1997) Mechanism and regulation of mRNA polyadenylation. Genes Dev 11: 2755-2766
10. Colgan DF, Murthy KG, Prives C, Manley JL (1996) Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 384: 282-285
11. Colgan DF, Murthy KG, Zhao W, Prives C, Manley JL (1998) Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites. EMBO J 17: 1053-1062
12. Copeland PR, Wormington M (2001) The mechanism and regulation of deadenylation: identification and characterization of Xenopus PARN. RNA 6: 875-886
13. Dehlin E, Wormington M, Korner CG, Wahle E (2000) Cap-dependent deadenylation of mRNA. EMBO J 19: 1079-1086
14. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A (2004) Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37: 112-119
15. Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z, Yamashita Y, Zheng D, Shyu AB (2007) Human TOB, an antiproli-ferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27: 7791-7801
16. Flaherty SM, Fortes P, Izaurralde E, Mattaj IW, Gilmartin GM (1997) Participation of the nuclear cap binding complex in pre-mRNA 3 processing. Proc Natl Acad Sci USA 22: 11893-11898
17. Gao M, Fritz DT, Ford LP, Wilusz J (2000) Interaction between a poly(A)-specific ribonuclease and the 5 cap influences mRNA deadenylation rates in vitro. Mol Cell 5: 479-488
18. Gao M, Wilusz CJ, Peltz SW, Wilusz J (2001) A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J 20: 1134-1143
19. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM (2006) Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcrip-tional program. Genes Dev 20: 601-612
20. Gowrishankar G, Winzen R, Bolling F, Ghebremedhin B, Redich N, Ritter B, Resch K, Kracht M, Holtmann H (2005) Inhibition of mRNA deadenylation and degradation by ultraviolet light. Biol Chem 12: 1287-1293
21. Hanawalt PC (1994) Transcription-coupled repair and human disease. Science 266: 1957-1958
22. Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T (2001) The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 18: 14537-14540
23. Hirose Y, Manley JL (1998) RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395: 93-96
24. Kartasova T, Cornelissen BJ, Belt P, van de Putte P (1987) Effects of UV, 4-NQO and TPA on gene expression in cultured human epidermal keratinocytes. Nucleic Acids Res 15: 5945-5962
25. Kim HS, Li H, Cevher M, Parmelee A, Fonseca D, Kleiman FE, Lee SB (2006) DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex. Cancer Res 66: 4561-5465
26. Kim JH, Richter JD (2006) Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation. Mol Cell 24: 173-183
27. Kleiman FE, Manley JL (1999) Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285: 1576-1579
28. Kleiman FE, Manley JL (2001) The BARD1-CstF-50 interaction links mRNA 3 end formation to DNA damage and tumor suppression. Cell 104: 743-753
29. Kleiman FE, Wu-Baer F, Fonseca D, Kaneko S, Baer R, Manley JL (2005) BRCA1/BARD1 inhibition of mRNA 3 processing involves targeted degradation of RNA polymerase II. Genes Dev 19: 1227-1237
30. Korner CG, Wahle E (1997) Poly(A) tail shortening by a mammalian poly(A)-specific 3-exoribonuclease. J Biol Chem 272: 10448-10456
31. Korner CG, Wormington M, Muckenthaler M, Schneider S, Dehlin E, Wahle E (1998) The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J 18: 5427-5437
32. Kumar A, Kurl RN, Kryworuchko M, Diaz-Mitoma F, Sharma S (1995) Differential effect of heat shock on RNA metabolism in human Burkitt's lymphoma B-cell lines. Leuk Res 19: 831-840
33. Lai WS, Kennington EA, Blackshear PJ (2003) Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol 23: 3798-3812
34. Lejeune F, Li X, Maquat LE (2003) Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol Cell 3: 536-538
35. Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay BC (1999) Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 118: 583-592
36. Maccoux LJ, Clements DN, Salway F, Day PJ (2007) Identification of new reference genes for the normalisation of canine osteoar-thritic joint tissue transcripts from microarray data. BMC Mol Biol 8: 62-72
37. Mandel CR, Bai Y, Tong L (2008) Protein factors in pre-mRNA 3-end processing. Cell Mol Life Sci 65: 1099-1122
38. Maquat LE (2004) Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2: 89-99
39. Martinez J, Ren YG, Nilsson P, Ehrenberg M, Virtanen A (2001) The mRNA cap structure stimulates rate of poly(A) removal and amplifies processivity of degradation. J Biol Chem 276: 27923-27929
40. Martinez J, Ren YG, Thuresson AC, Hellman U, Astrom J, Virtanen A (2000) A 54-kDa fragment of the poly(A)-specific ribonuclease is an oligomeric, processive, and cap-interacting poly(A)-specific 3 exonuclease. J Biol Chem 275: 24222-24230
41. Mauxion F, Faux C, Séraphin B (2008) The BTG2 protein is a general activator of mRNA deadenylation. EMBO J 27: 1039-1048
42. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, Patterson SD, Wickens M, Bentley DL (1997) The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385: 357-361
43. Milde-Langosch K (2005) The Fos family of transcription factors and their role in tumorigenesis. Eur J Cancer 41: 2449-2461
44. Mirkin N, Fonseca D, Mohammed S, Cevher MA, Manley JL, Kleiman FE (2008) The 3 processing factor CstF functions in the DNA repair response. Nucleic Acids Res 36: 1792-1804
45. Mitchell P, Tollervey D (2000) mRNA stability in eukaryotes. Curr Opin Genet Dev 10: 193-198
46. Moraes KC, Wilusz CJ, Wilusz J (2006) CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 12: 1084-1091
47. Nilsson P, Henriksson N, Niedzwiecka A, Balatsos NAA, Kokkoris K, Eriksson J, Virtanen A (2007) A multifunctional RNA recognition motif in poly(A)-specific ribonuclease with cap and poly(A) binding properties. J Biol Chem 28: 32902-32911
48. Nilsson P, Virtanen A (2006) Expression and purification of recom-binant poly(A)-specific ribonuclease (PARN). Int J Biol Macromol 39: 95-99
49. Parker R, Song H (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11: 121-127
50. Scorilas A (2002) Polyadenylate polymerase (PAP) and 3 end pre-mRNA processing: function, assays, and association with disease. Crit Rev Clin Lab Sci 39: 193-224
51. Shatkin AJ, Manley JL (2000) The ends of the affair: capping and polyadenylation. Nat Struct Biol 7: 838-842
52. Takagaki Y, Manley JL (1998) Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol Cell 2: 761-771
53. Takagaki Y, Seipelt RL, Peterson ML, Manley JL (1996) The poly-adenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87: 941-952
54. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20: 760-769
55. Wilusz CJ, Wormington M, Peltz SW (2001) The cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol 2: 237-246
56. Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid dead-enylation of mRNA. Proc Natl Acad Sci USA 103: 3951-3952
57. 7GpppG binding to poly(A)-specific ribonuclease (PARN). Structure 17: 276-286
58. Wu M, Reuter M, Lilie H, Liu Y, Wahle E, Song H (2005) Structural insight into poly(A) binding and catalytic mechanism of human PARN. EMBO J 24: 4082-4093
59. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH (2001) Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 5168-5178
60. Zhang B, Pan X, Cobb GP, Anderson TA (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12
61. Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3 ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63: 405-445
62. Zhao W, Manley JL (1998) Deregulation of poly(A) polymerase interferes with cell growth. Mol Cell Biol 18: 5010-5020